2-(4-BROMOPHENYL)-1,1,1-TRIFLUOROPROPAN-2-OL, 95.0%, 2.5g

2-Bromo-5-(4-hexylphenyl)thiophene, 98%, 1g

Methyl 2,4-difluorobenzoate, 98.0%, 500g

L-Histidine, min. 98.5%, Ph.Eur., for biochemistry, 1 kg, plastic packaging.

3-Bromo-N-cyclopropyl-N-(4-methoxybenzyl)benzenesulfonamide, 95%, 250mg

METHYL 4-(4-METHYLPHENYL)-4-OXOBUTANOATE, 97.0%, 250mg

2,7-Naphthyridin-1-amine, 95.0%, 5g

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 1g

3,5-Dimethylpyrazole>98.0%(GC)(T)500g

TERT-BUTYL 4-(3-((METHYLSULFONYL)OXY)PROPYL)PIPERAZINE-1-CARBOXYLATE, 95.0%, 5g

Methyl 3,4-difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

O-Sulfo-L-serine, 95.0%, 250mg

Cyclohexanecarboxylic acid hydrazide, 95.0%, 100mg